molecular prognostic and classification of malignant melanoma based on markers selected from the list consisting of RGS1, NCOA3, SPP1, PHIP

摘要

A method of providing a prognosis for melanoma in a subject, the method comprising the steps of: (a) contacting a biological sample from the subject with reagents that specifically bind to selected markers comprising: (i) RGS1 polypeptides, NCOA3 , SPP1, and PHIP, or (ii) nucleic acids encoding the polypeptides, wherein there is at least one reagent binding to each marker; and (b) determining whether each of the selected markers is overexpressed or not in the sample; thereby providing a prognosis for melanoma in the subject.